© 2021 MJH Life Sciences and OncLive. All rights reserved.
2 Clarke DriveSuite 100Cranbury, NJ 08512
© 2021 MJH Life Sciences™ and OncLive. All rights reserved.
May 18, 2020
OncLive interviewed experts on novel treatments in HER2-positive breast cancer.
March 20, 2020
Forrest Thompson, MD, discusses sequencing strategies in HER2-positive breast cancer.
March 19, 2020
Sara A. Hurvitz, MD, discusses available treatment options in early-stage HER2-positive breast cancer.
Oludamilola (Lola) A. Olajide, MD, discusses managing the risk of interstitial lung disease with fam-trastuzumab deruxtecan-nxki in breast cancer.
March 12, 2020
Elisa Krill-Jackson, MD, discusses the potential future utility of fam-trastuzumab deruxtecan-nxki in the treatment of patients with metastatic breast cancer.
March 11, 2020
Sara A. Hurvitz, MD, discusses the need for additional research with fam-trastuzumab deruxtecan-nxki in HER2-positive breast cancer.